Menu
Log in
Forgot password



Your Resource for Neurotherapeutics Discovery and Development


Log in
  • Home
  • ASENT 2026 Annual Meeting and Clinical Trials Course

ASENT 2026 Annual Meeting and Clinical Trials Course

  • March 02, 2026
  • 8:00 AM
  • March 06, 2026
  • 1:00 PM
  • Hyatt Regency Bethesda, Bethesda, MD

Registration

(depends on selected options)

Base fee:
  • Attendees to ASENT 2026 Clinical Trial Course Only

    (If also attending the annual meeting, register using the appropriate ticket type and select add clinical trials for additional $150)
  • ASENT 2026 Annual Meeting Faculty and Chairs
  • Available to the following
    ASENT Member types: AAN Members, Academic Members, Advocacy Members, Clinical Members, Retired Members, Government Members, and JSNT Members of ASENT.
  • Academic, Advocacy, Clinicians, Retired, Government, and JSNT attendees of ASENT.
  • Attendees who are currently Interns, Junior Residents and Fellows, PhD Candidates, and Students (Medical or Graduate)
    or
    Those who live in low and middle income countries according to the World Bank.
Register

ABOUT ASENT 2026 Annual Meeting
and Clinical Trials Course

The ASENT 2026 Annual Meeting, the premier neurotherapeutics conference will take place March 2 - 6, 2026 at the Hyatt Regency Bethesda in Bethesda, MD. This scientific meeting is where senior leaders from leading payers, providers, employers, investors, fast-growing startups, pharma, policymakers, funders and innovation centers gather with one central focus, improving the process of bringing neurotherapeutics to market.

ASENT's popular Neurotherapeutic Clinical Trials Course runs March 2-3. Followed by the ASENT 2026 Annual Meeting, which runs March 4-6, all in one location.

Attendees interested in participating in both the Clinical Trials Course and Annual Meeting are encouraged to select the appropriate registration level and then add on the clinical trials course during the registration process for an additional $150.

The plenary sessions, panel discussions, outstanding pipeline presentations and poster sessions focus on the latest science in neurotherapeutics. The conference content will focus on the latest science in neurotherapeutics including innovations across disease states, novel delivery systems, gene therapy and biomarkers, and of course the latest drug therapies and devices. The event features plenary sessions, panel discussions, satellite luncheons, networking meetings, pipeline presentations and poster sessions.

WHO ATTENDS

Chief Medical Officers | Chief Scientific Officers | Clinician-Investigators | Clinical Research Professionals | Clinical Scientists | Clinical Trial Unit Directors | CROs | Drug Discovery Neuroscientists | Founders | Funders | Innovation Centers | Investors / Venture Capital | Journal Editors | Medical Directors | MSLs | Patient Advocates | Regulatory Science Professionals | Research Scientists | Trainees (Basic, Clinical, Translational)

Cancellation Policy

You may cancel your registration for a refund through February 1, 2026 by contacting our offices directly. Cancellations will be refunded less a $50 cancellation fee. No refunds will be granted for cancellations on February 15, 2026 and after.

Powered by Wild Apricot Membership Software